Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Using deep rTMS to treat neuropathic pain and fibromyalgia

Official title: Effects of Deep rTMS in Neuropathic Pain or Fibromyalgia : a Bicenter Randomized Sham Controlled Study

Run by Hospital Ambroise Paré Paris · NCT06250491 · Data updated 2026-11-12

This study is testing if a special type of brain stimulation can help people with neuropathic pain or fibromyalgia feel less pain over three months.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment70 (estimated)
SponsorHospital Ambroise Paré Paris
Academic / other
Locations2 sites (Boulogne-Billancourt and 1 other locations)
StatusRecruiting
StartedJanuary 30, 2024
Main results expectedJanuary 30, 2027
Study endsApril 30, 2027
Registry record updatedMarch 27, 2026
Trial IDNCT06250491 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with chronic neuropathic pain or fibromyalgia lasting at least six months and experiencing daily pain rated at 4/10 or higher.

Probably not a fit

Patients with contraindications to rTMS, prior rTMS treatment, or severe progressive conditions such as cancer may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the efficacy and safety of deep repetitive transcranial magnetic stimulation (rTMS) using an H-coil for patients suffering from neuropathic pain or fibromyalgia. It is a randomized, double-blind, sham-controlled trial lasting three months, where participants will receive either active or sham rTMS sessions. The treatment involves five daily sessions followed by weekly sessions, with a total of up to ten weeks of treatment. The primary outcome measure is the percentage of pain relief assessed at week 13.

Why it matters

Potential benefit: If successful, this treatment could provide significant pain relief for patients suffering from chronic neuropathic pain or fibromyalgia.

How similar studies have gone: Previous studies have shown promising results with rTMS for chronic pain conditions, suggesting potential efficacy for this novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Chronic pain ≥ 6 months, at least 4/10 on a 0-10 NRS, present every day or nearly every day
* Neuropathic pain (confirmed with Douleur Neuropathique en 4 questions and international criteria from NeuPSIG) or fibromyalgia (revised ACR criteria)
* Stable concomitant medications for pain for at least one month
* Able to fill out questionnaires and understand and speak French

Exclusion Criteria:

* Contraindications to rTMS
* Prior treatment with rTMS
* Progressive severe condition (eg cancer)
* Psychosis
* Psychoactive drug abuse

Where it's running

  • Inserm U987
    Boulogne-Billancourt, France
    Recruiting
  • Centre d'Evaluation et de Traitement de la douleur
    Paris, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.